The whole thing is slick and looks like it could get a jumpstart on BTS UIA's.
The "short token" is the most interesting thing here, I think.
http://t0.com/shorttoken
Wondering if their tech stacks up though.
I like it. No MPAs or referral program, which are bigger growth products than UIAs imo.
I disagree. Byrne is appealing to the financial industry, securing partnerships with broker dealers and going through the regulatory process. Their using UIA's for securities, where as we are using them for tokens. Its not the same thing.
Referral program isn't going to take off as much as people think and MPA's are really only for the crypto community, which generally doesn't appreciate them because BTS isn't BTC and as such is an inferior collateral.
While I agree stock is generally viewed as inferior collateral to currency, esp. BTC in this market. I think the referral program actually has a good chance of being extremely successful especially with later possible additions of things like PM's, Blockchain-based gambling and other high transaction generators.
MPA's provided they are viewed by the market as safer than the IOU currency options provided by centralised exchanges have huge potential, because BTC volatility is a huge problem for a wide range of crypto-serving businesses. The potential market beyond that for private, globally accessible currencies like BitUSD is just unbelievably massive and will take off fairly quickly once they're satisfactorily proven within this market.
Competitors like Bitreserve, who have a target-able, centralised offering using a fractional reserve bank account (Who I also think may still be using a fiat balance to back up their gold, silver and other positions too) already has nearly $3 million of BitAssets and 57% MoM growth for the last 30 days.
https://changemoney.org/ While that growth rate isn't sustainable and we'll need to see how they do after the next 6-12 months, if BTS 2.0 can replicate that to a degree (which I think it can as it is superior) it would be extremely valuable in the next 12-24 months.